Compare RDN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RDN | AMRX |
|---|---|---|
| Founded | 1977 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.7B |
| IPO Year | 1992 | N/A |
| Metric | RDN | AMRX |
|---|---|---|
| Price | $34.68 | $11.86 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $38.00 | $12.67 |
| AVG Volume (30 Days) | 720.3K | ★ 1.8M |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | ★ 3.60 | N/A |
| EPS | ★ 4.00 | 0.02 |
| Revenue | $1,273,225,000.00 | ★ $2,934,959,000.00 |
| Revenue This Year | N/A | $9.99 |
| Revenue Next Year | $2.43 | $6.67 |
| P/E Ratio | ★ $8.69 | $733.02 |
| Revenue Growth | 2.49 | ★ 9.50 |
| 52 Week Low | $29.32 | $6.69 |
| 52 Week High | $38.84 | $12.68 |
| Indicator | RDN | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.26 | 55.12 |
| Support Level | $35.23 | $11.97 |
| Resistance Level | $35.96 | $12.68 |
| Average True Range (ATR) | 0.69 | 0.33 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 30.05 | 37.59 |
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one business segment Mortgage Insurance. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for the benefit of mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans, and also offers other credit risk management solutions, including contract underwriting, to customers. It also provides other mortgage and real estate products and services through Mortgage Conduit, Title, Real Estate Services, and Real Estate Technology businesses.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.